Marguerite Prevotat

Marguerite Prevotat has extensive experience in global regulatory affairs, particularly in rare diseases and oncology. At Ipsen, from March 2017 to October 2020, Marguerite served as Vice President Global Regulatory Affairs Rare Diseases, overseeing regulatory and development strategies for global product registration. Prior to Ipsen, from June 2001 to February 2017, Marguerite held several roles at Pierre Fabre, including Senior Director Global Regulatory Affairs Rare Diseases and Global Regulatory Affairs Director, managing regulatory submissions and communications with authorities in over 90 countries. Earlier in Marguerite's career, a role as Global Project Leader focused on development program and registration strategies, along with regulatory documentation, was undertaken, as well as a position as Regulatory Project Manager at Aventis from January 2000 to January 2001. Marguerite earned a Doctorate in Pharmacy from Paris-Sud University (Paris XI) in 2000.